LONDON, 29 October 2021: Arix Bioscience plc (LSE: ARIX, “Arix”), a global venture capital company focused on investing in and building breakthrough biotech companies, today notes that its portfolio company, Aura Biosciences, Inc., (“Aura”), has announced the pricing of its initial public offering of 5,400,000 shares of common stock at a public offering price of […]
Tag Archive for: arix
LONDON, 12 August 2021: Arix Bioscience plc (“Arix”, LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, today announces its interim results for the period ended 30 June 2021. Read more
Jonathan Tobin, Managing Director of Arix, talks to Vox Markets
A video panel by Optimum in partnership with One Nucleus for ON Helix event held virtually in July 2020
Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic.